Our top pick for
Luxfer Holdings PLC is a specialty industrial machinery business based in the US. Luxfer shares (LXFR) are listed on the NYSE and all prices are listed in US Dollars. Luxfer employs 1,600 staff and has a trailing 12-month revenue of around USD$383.2 million.
|52-week range||USD$9.9168 - USD$19.56|
|50-day moving average||USD$17.4836|
|200-day moving average||USD$15.0994|
|Wall St. target price||USD$21.5|
|Dividend yield||USD$0.5 (2.57%)|
|Earnings per share (TTM)||USD$0.37|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Luxfer stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Luxfer's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Luxfer's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 55x. In other words, Luxfer shares trade at around 55x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Luxfer's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.2482. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Luxfer's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Luxfer's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$54.3 million.
The EBITDA is a measure of a Luxfer's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$383.2 million|
|Operating margin TTM||10.31%|
|Gross profit TTM||USD$108 million|
|Return on assets TTM||6.48%|
|Return on equity TTM||5.9%|
|Market capitalisation||USD$543.9 million|
TTM: trailing 12 months
There are currently 231,351 Luxfer shares held short by investors – that's known as Luxfer's "short interest". This figure is 4.1% down from 241,282 last month.
There are a few different ways that this level of interest in shorting Luxfer shares can be evaluated.
Luxfer's "short interest ratio" (SIR) is the quantity of Luxfer shares currently shorted divided by the average quantity of Luxfer shares traded daily (recently around 84434.671532847). Luxfer's SIR currently stands at 2.74. In other words for every 100,000 Luxfer shares traded daily on the market, roughly 2740 shares are currently held short.
However Luxfer's short interest can also be evaluated against the total number of Luxfer shares, or, against the total number of tradable Luxfer shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Luxfer's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Luxfer shares in existence, roughly 10 shares are currently held short) or 0.0125% of the tradable shares (for every 100,000 tradable Luxfer shares, roughly 13 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Luxfer.
Find out more about how you can short Luxfer stock.
Dividend payout ratio: 50.51% of net profits
Recently Luxfer has paid out, on average, around 50.51% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.68% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Luxfer shareholders could enjoy a 2.68% return on their shares, in the form of dividend payments. In Luxfer's case, that would currently equate to about $0.5 per share.
Luxfer's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
Luxfer's most recent dividend payout was on 4 February 2021. The latest dividend was paid out to all shareholders who bought their shares by 14 January 2021 (the "ex-dividend date").
Over the last 12 months, Luxfer's shares have ranged in value from as little as $9.9168 up to $19.56. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Luxfer's is 0.951. This would suggest that Luxfer's shares are less volatile than average (for this exchange).
Luxfer Holdings PLC, a materials technology company, designs, manufactures, and supplies high-performance materials, components, and high-pressure gas cylinders for transportation, defense and emergency response, healthcare, and general industrial end-market applications. It operates in two segments, Gas Cylinders and Elektron. The Gas Cylinders segment manufactures and markets aluminum, titanium, and carbon composite cylinders, which are used for self-contained breathing apparatus that are used by firefighters and other emergency-responders, as well as scuba divers and personnel in potentially hazardous environments, such as mines; and aluminum and composite cylinders for use in the containment of oxygen and other medical gases that are used by patients, healthcare facilities, and laboratories. This segment also offers carbon composite cylinders for compressed natural gas and hydrogen containment in alternative fuel vehicles; lightweight aluminum cylinders for a variety of industrial applications, such as fire extinguishers and containment of high-purity specialty gases; and lightweight aluminum and titanium panels primarily for use in the aerospace and luxury-auto industries. The Elektron segment focuses on specialty materials based on magnesium, zircon sand, and rare earths. It develops and manufactures magnesium alloys; magnesium powders; and magnesium, copper, and zinc photoengraving plates for graphic arts and luxury packaging. This segment also develops and manufactures zirconium-based materials and oxides used as catalysts and in the manufacture of advanced ceramics, fiber-optic fuel cells, and other performance products. Luxfer Holdings PLC has operations in the United States, the United Kingdom, Germany, Italy, France, rest of Europe, the Asia Pacific, Canada, South America, Latin America, and Africa. The company was founded in 1898 and is headquartered in Manchester, the United Kingdom.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.